When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Stoneridge remains a 'buy' despite near-term automotive sector headwinds and a 27.9% stock decline since reaffirmation. 2025 revenue and EBITDA guidance were revised downward, but multi-year contract wins—especially for MirrorEye—support optimism for outsized long-term growth. Current valuation is not exceptional versus peers, but if SRI achieves its 2026–2029 targets, shares could be extremely undervalued.

LOS ANGELES, Dec. 26, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Firefly Aerospace Inc. (“Firefly” or “the Company”) (NASDAQ: FLY) for violations of the federal securities laws. Investors who purchased the Company's securities pursuant and/or traceable to the Company's Offering Documents issued in connection with its initial public offering (“IPO”) conducted on August 7, 2025, and/or between August 7, 2025 and September 29, 2025, both dates inclusive (the "Class Period"), are encouraged to contact the firm before January 12, 2026.

ING Groep delivered robust Q3 results, maintaining strong profitability and capital generation amidst a stable eurozone outlook. ING's CET1 capital ratio stands at 13.4%, enabling a €1.1B share buyback and €500M dividend, with continued capital build expected. Dividend policy targets ~50% payout and ongoing buybacks, supporting rising EPS and yield; 2027 consensus implies a 5.4% yield at 9x earnings.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Synopsys To Contact Him Directly To Discuss Their Options

RADNOR, Pa. , Dec. 26, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of CoreWeave, Inc. (NASDAQ: CRWV) ("CoreWeave").

Biohaven Ltd (NYSE:BHVN) stock is down 3.2% to trade at $10.46 at last glance, amid reports that the biopharmaceutical name's drug to treat major depressive disorder did not meet the primary goal of a phase 2 trial.

Rocket Pharmaceuticals is rated Buy with a $17 price target, reflecting a deep disconnect between intrinsic value and current valuation. RCKT's bullish thesis hinges on a high-probability LAD-1 approval in March 2026 and the pivotal Danon's disease trial resuming with an amended, safer protocol. Risk-adjusted DCF values Danon's and LAD-1 programs at ~$700M, far exceeding the current $151M EV, even under conservative or bear-case assumptions.

Buying low and selling high is a tried-and-true strategy for both buy-and-hold investors and active traders. When a stock is trading at or near its 52-week low, the stock price is trading at one of its lowest points of the year.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In SLM To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in SLM between July 25, 2025 and August 14, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Dec. 26, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against SLM Corporation ("SLM" or the "Company") …

CVNA shares have surged 117% YTD. Freshly added to the S&P 500, the company appears well-positioned to sustain its rally into 2026.

SNA is leaning on RCI-driven efficiency, innovative tools and deeper repair-shop ties to fuel resilient growth across automotive and industrial markets.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In F5 To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in F5 between October 28, 2024 and October 27, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Dec. 26, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against F5, Inc. ("F5" or the "Company") …

Quanta Services, Inc. PWR is uniquely positioned to meet the explosive rise in power demand driven by data centers, advanced manufacturing and electrification. As the United States' energy landscape undergoes a fundamental transformation, the company is witnessing strong infrastructure demand.

CRMD's $300M Melinta acquisition adds seven products and helps raise 2025 revenue guidance, but questions remain over easing DefenCath reliance.

Palomar Holdings rides on a fee-based PLMR-FRONT platform, premium growth, rising investment income and risk transfer strategy.

Ralph Lauren's digital push is paying off as personalization, omnichannel and Asia growth lift sales and fuel its Next Great Chapter strategy.

Great Lakes Dredge & Dock Corporation GLDD is gaining from the mid and long-term opportunities laid out because of the accelerated coastal and port infrastructure spending in the United States. As of Sept.

Amazon.com stands out as tech stocks rebound in a Santa Claus rally, with easing AI fears and strong earnings outlook lifting S&P 500 sentiment.

Cincinnati Financial stock gains from new business-written premiums, an agent-focused business model, improved interest income, and effective capital deployment.